We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Fiber-Optic Microscope Helps Detect Cancer

By LabMedica International staff writers
Posted on 01 May 2014
An inexpensive, portable and reusable endoscopic microscope has been developed that will help clinicians detect and diagnose early-stage disease, primarily cancer.

An endoscopic microscope is a tool or technique that obtains histological images from inside the human body in real-time and some clinicians consider it as an optical biopsy. More...


An engineering scientist at the University of Arkansas (Fayetteville, AR, USA) has developed an inexpensive, endoscopic microscope capable of producing high-resolution, subcellular images of tissue in real time. The fiber-optic device, which is portable, reusable and easily packaged with conventional endoscopes, will help clinicians detect and diagnose early-stage disease, primarily cancer.

The system, developed also serves as an intraoperative monitoring device by providing a preview biopsy that is, helping clinicians target ideal locations on lesions prior to and during surgical biopsies and by capturing high-resolution images of tumor margins in real time. The latter will help surgeons know whether they have totally removed a tumor. The microscope is built from a single fiber optic bundle that includes thousands of flexible, small-caliber fibers. This bundle is roughly one millimeter in diameter and could be inserted into the biopsy channel of a standard endoscope.

The system requires a topical contrast agent to facilitate fluorescent imaging. It can produce images at sub-cellular resolution, which allows clinicians to see the early stages of cell deformations that could lead to precancerous conditions. The probe can be sterilized and reused. The entire system, which fits into a conventional-sized briefcase, costs approximately USD 2,500.

A prototype of the system has been tested at the M.D. Anderson Cancer Center (Houston, TX, USA). Studies there focused on various conditions leading to esophageal cancer. The work provided high-resolution images of cell structure and morphology, specifically nuclear-to-cytoplasmic ratio, a critical indicator of cell behavior leading up to a precancerous condition. Results obtained from the endoscopic microscope were confirmed by standard histopathological examination of biopsied tissue.

Timothy Muldoon, MD, PhD, an assistant professor of biomedical engineering who developed the endoscopic microscope, said, “My dream is to disseminate this technology to a broad scope of medical facilities, hospitals and various clinics, of course, but also to take it into underserved and rural, even remote, areas. Its compactness and portability will allow us to do this.”

Related Links:

University of Arkansas
M.D. Anderson Cancer Center 



New
Gold Member
Automatic Hematology Analyzer
CF9600
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Electrolyte Analyzer
BKE-B
New
Thyroid Test
Anti-Thyroid EIA Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Accurate immunotherapy selection for esophageal and GEJ carcinomas depends on consistent PD-L1 assessment (credit: Adobe Stock)

FDA Approval Expands Use of PD-L1 Companion Diagnostic in Esophageal and GEJ Carcinomas

Esophageal and gastroesophageal junction carcinomas (GEJ) have a poor prognosis, with approximately 16,250 deaths in the United States in 2025 and a five-year relative survival of 21.9%.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.